Page last updated: 2024-11-04

sulfamethazine and Menopause

sulfamethazine has been researched along with Menopause in 1 studies

Sulfamethazine: A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
sulfamethazine : A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position.

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research Excerpts

ExcerptRelevanceReference
"Hepatic acetylator phenotype has been determined, using sulfamethazine, in 81 white Spanish women with histologically proven breast cancer and in 75 adequate female controls."3.67Hepatic acetylator polymorphism in breast cancer patients. ( Fernández, MJ; Jara, C; Ladero, JM; Lázaro, C; Muñoz, JJ; Palmeiro, R; Pérez-Manga, G, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ladero, JM1
Fernández, MJ1
Palmeiro, R1
Muñoz, JJ1
Jara, C1
Lázaro, C1
Pérez-Manga, G1

Other Studies

1 other study available for sulfamethazine and Menopause

ArticleYear
Hepatic acetylator polymorphism in breast cancer patients.
    Oncology, 1987, Volume: 44, Issue:6

    Topics: Acetylation; Acetyltransferases; Adult; Breast Neoplasms; Female; Humans; Liver; Menopause; Middle A

1987